145
- Meredith LW, Harris HJ, Wilson GK, Fletcher NF, Balfe P, McKeating JA (2013) Early
infection events highlight the limited transmissibility of hepatitis C virus in vitro. J Hepatol
58:1074–1080 - Hedegaard DL, Tully DC, Rowe IA, Reynolds GM, Bean DJ, Hu K, Davis C, Wilhelm A,
Ogilvie CB, Power KA, Tarr AW, Kelly D, Allen TM, Balfe P, McKeating JA (2016) High
resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization
in end stage liver disease. J Hepatol 66:28 - Kanwal F, Kramer JR, Ilyas J, Duan Z, El-Serag HB (2014) HCV genotype 3 is associated
with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S.
veterans with HCV. Hepatology 60:98–105 - Raimondi S, Bruno S, Mondelli MU, Maisonneuve P (2009) Hepatitis C virus genotype
1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol
50:1142–1154 - El-Shamy A, Eng FJ, Doyle EH, Klepper AL, Sun X, Sangiovanni A, Iavarone M, Colombo
M, Schwartz RE, Hoshida Y, Branch AD (2015) A cell culture system for distinguishing
hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.
J Hepatol 63:1323–1333 - Korba B, Shetty K, Medvedev A, Viswanathan P, Varghese R, Zhou B, Roy R, Makambi K,
Ressom H, Loffredo CA (2015) Hepatitis C virus genotype 1a core gene nucleotide patterns
associated with hepatocellular carcinoma risk. J Gen Virol 96:2928–2937 - Charles ED, Dustin LB (2009) Hepatitis C virus-induced cryoglobulinemia. Kidney Int
76:818–824 - Iqbal T, Mahale P, Turturro F, Kyvernitakis A, Torres HA (2016) Prevalence and association
of hepatitis C virus infection with different types of lymphoma. Int J Cancer 138:1035–1037 - Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S (2013) Hepatitis C-associated
B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical manage-
ment. J Hepatol 59:169–177 - Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton
M, Rosa D, Grandi G, Abrignani S (1998) Binding of hepatitis C virus to CD81. Science
282:938–941 - Ng PP, Kuo CC, Wang S, Einav S, Arcaini L, Paulli M, Portlock CS, Marcotrigiano J, Tarr A,
Ball J, Levy R, Levy S (2014) B-cell receptors expressed by lymphomas of hepatitis C virus
(HCV)-infected patients rarely react with the viral proteins. Blood 123:1512–1515 - Dai B, Chen AY, Corkum CP, Peroutka RJ, Landon A, Houng S, Muniandy PA, Zhang Y,
Lehrmann E, Mazan-Mamczarz K, Steinhardt J, Shlyak M, Chen QC, Becker KG, Livak F,
Michalak TI, Talwani R, Gartenhaus RB (2016) Hepatitis C virus upregulates B-cell recep-
tor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders.
Oncogene 35:2979–2990 - Vannata B, Zucca E (2014) Hepatitis C virus-associated B-cell non-Hodgkin lymphomas.
hematology/the education program of the American Society of Hematology. Am Soc Hematol
Educ Program 2014:590–598 - Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM,
Lai MM (2003) Establishment of B-cell lymphoma cell lines persistently infected with hepa-
titis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77:2134–2146 - Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, Rice CM, Dustin LB
(2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear
cells. Hepatology 48:1843–1850 - Pawlotsky JM (2013) Treatment of chronic hepatitis C: current and future. Curr Top Microbiol
Immunol 369:321–342 - Reig M, Marino Z, Perello C, Inarrairaegui M, Ribeiro A, Lens S, Diaz A, Vilana R, Darnell
A, Varela M, Sangro B, Calleja JL, Forns X, Bruix J (2016) Unexpected high rate of early
tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.
J Hepatol 65:719
8 HCV-Associated Cancers